Learn / AKTS
NASDAQ: AKTS
Aktis Oncology (AKTS) stock, explained like you're 5
Aktis Oncology trades on the Nasdaq under the ticker AKTS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1 billion dollars.
- Ticker
- AKTS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1 billion dollars
Is Aktis Oncology a small, medium or large cap company?
No. Aktis Oncology is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Aktis Oncology makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AKTS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Aktis Oncology: Padcev Is Building The Market It Wants (Seeking Alpha)
- A Look At Aktis Oncology (AKTS) Valuation After Recent Share Price Rebound (Yahoo Finance)
- AKTS Forecast Price Target Prediction for 2027 (TradingView)
- Aktis Oncology (NASDAQ:AKTS) Receives Average Recommendation of "Moderate Buy" from Brokerages (MarketBeat)
- After selling 50,000 shares in July, an Aktis Oncology (AKTS) officer plans another sale. (Stock Titan)
Follow AKTS in your daily brief
Each trading day at 5 PM ET we post what happened to Aktis Oncology and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AKTS
Questions about Aktis Oncology stock
What does Aktis Oncology do?
Aktis Oncology trades on the Nasdaq under the ticker AKTS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1 billion dollars.
What is the ticker symbol for Aktis Oncology?
Aktis Oncology trades under the ticker AKTS on the Nasdaq.
What is Aktis Oncology's market cap?
Aktis Oncology is a small cap stock with a market cap of about 1 billion dollars.
How does Aktis Oncology make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AKTS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AKTS stock every day?
Add AKTS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.